Search

everythinglearnresearchcommunity

for

Search:↓

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Pantethine may boost the immune system's ability to fight sarcoma.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Fetal skin has unique immune cells different from adult skin.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.